Form 4: MannKind Director Mundkur Receives RSU Grant

Director Christine Mundkur was granted 82,781 restricted stock units by MannKind Corporation on May 20, 2026.

Summary

• Director Christine Mundkur received a grant of 82,781 restricted stock units (RSUs) on May 20, 2026.
• Each RSU represents a contingent right to receive one share of MannKind common stock.
• The RSUs vested on the grant date, but delivery of the underlying shares is deferred until the director separates from the board.
• The filing includes a correction to prior holdings, noting that 226,818 shares previously reported as deferred RSUs were inadvertently included in Table I.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation and a minor correction of prior reporting errors.

Positives

• Alignment of director interests with long-term shareholder value through equity-based compensation.

Negatives

• Correction of prior reporting errors regarding the classification of 226,818 shares in Table I.

Risks

• Potential for future administrative or reporting errors in SEC filings.
• Market volatility affecting the value of equity-based compensation.

Future Outlook

The shares underlying the 82,781 RSUs will be delivered upon the director's separation from the board of directors.

Industry Context

StockSavvy.ai notes that equity grants to board members are standard practice in the biotechnology sector to ensure alignment with long-term corporate governance and performance goals.

Comparison to Industry Standards

• The use of deferred RSU delivery until board departure is a common retention and alignment mechanism among mid-cap biotech firms.
• Reporting corrections are occasionally necessary in complex equity compensation structures, though they highlight the need for rigorous internal controls.

Stakeholder Impact

• Shareholders should note the correction in reported beneficial ownership figures.

Next Steps

• Delivery of 82,781 shares upon the director's future separation from the board.

Key Dates

Keywords

MannKind, MNKD, Form 4, Insider Trading, Director Compensation, Restricted Stock Units